The PTEN-PI3K-mTOR complex 1 (mTORC1) pathway was shown to regulate the stability of SAMDC (AMD1), which controls the use of SAM for polyamine synthesis in prostate cancer [104,105]. Here, AMD1 is linked to prostate cancer.